AEG35156: Phase IIb started

Aegera began an open-label, international Phase IIb trial

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE